Royalty Pharma Research and Development Expenses 2019-2025 | RPRX
Royalty Pharma research and development expenses for the twelve months ending March 31, 2025 were $52M, a 0% increase year-over-year.
- Royalty Pharma annual research and development expenses for 2024 were $0.002B, a 96.15% decline from 2023.
- Royalty Pharma annual research and development expenses for 2023 were $0.052B, a 70.64% decline from 2022.
- Royalty Pharma annual research and development expenses for 2022 were $0.177B, a 11.48% decline from 2021.